Skip to content

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Rectal Indomethacin Versus Intraperitoneal Lidocaine for Analgesia After Laparoscopic Cholecystectomy

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04964180
Enrollment
80
Registered
2021-07-15
Start date
2020-05-01
Completion date
2021-06-20
Last updated
2021-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Post-Operative Pain

Brief summary

Hospitals, Qena, Egypt in period between May 2020 to May 2021.eighty patients was scheduled to elective laparoscopic cholecystectomy , divided Into two groups randomly using closed envelop method. Group IP lidocaine(40 patients ) received 200 ml saline containing 200 mg 2%lidocaine immediately after abdominal cO2 insufflation( pneumoperitoneum) the surgeon sprayed the total solution on the upper surface of the liver under the right subdiaphragmatic space, left subdiaphragmatic space and around the cholecystectomy site , all patients were maintained in trendelenberg position. At the end of the laparoscopic procedure, group indomethacin (40 patients) recived two 100 mg indomethacin rectal suppositories 2 hours prior to surgery

Interventions

two 100 mg indomethacin rectal suppositories 2 hours prior to surgery

200 ml saline containing 200 mg 2%lidocaine intraperitoneal insilltation

Sponsors

South Valley University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* .ASA physical status 1-2 patients. * 18-60 years old .

Exclusion criteria

* using or allergic to nonsteroidal anti inflammatory drugs (NSAIDs) or aspirin . * history of serious hepatic disease. * renal or gastrointestinal disease. * bleeding disorder. * body mass index BMI \<18 or ˃30 m2/kg. * history of abdominal surgery or chronic pain disorder other than gallbladder. * disease or allergy to lidocaine.

Design outcomes

Primary

MeasureTime frameDescription
VAS scores postoperative24 hours posoperativea standard 10-cm VAS was used, where one end of the scale represented no pain (0 cm), and the other end the most severe pain imaginable (10 cm), the distance in centimeters being taken as the pain score
postoperative opoiods analgesics requirements24 hours postoperativewe used (iv pethidine )whenever the patient complained of pain. IV pethidine injection 25-50 mg was given as rescue analgesic whenever the patient experienced pain ≥ to 5 VAS

Secondary

MeasureTime frameDescription
Pain starting time after surgery and Pethidine required first time.24 hours postoperativePain starting time after surgery and Pethidine required first time.

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026